Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Insulin resistance plays a key role in PCOS, and lifestyle changes, weight loss, and medications like metformin can help manage it.

Male pattern hair loss is mainly caused by genetics and hormones, especially DHT.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Higher levels of small, dense LDL cholesterol are linked to a greater risk of heart attack in young adults.

Women with androgenic alopecia may have a higher risk of artery problems.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

CAR is a useful marker for assessing alopecia areata severity.

Higher ischemia-modified albumin levels are linked to acne severity.

Early onset baldness may be linked to thicker artery walls.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Higher stress levels were found about two weeks before a heart attack.

Women with hair loss may have higher heart disease risk.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Severe alopecia areata may increase the risk of hidden artery disease.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Inclisiran is effective at lowering cholesterol.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

People with alopecia areata have more inflammation but similar heart risk as healthy people.

Age, diabetes, and cardiogenic shock at PCI are key factors linked to in-hospital death in STEMI patients with hypertension.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Alopecia areata may increase the risk of cardiovascular disease.